Marco Schiuma
Marco Schiuma
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, tuberculosis | Recruiting | Phase 4 | 2026-05-13 | NCT07477119 |